JPRN-UMIN000009586已完成未知
The additive effect of Eldecalcitol for glucocorticoid induced osteoporosis responding poorly to Alendronate. - The additive effect of Eldecalcitol for glucocorticoid induced osteoporosis responding poorly to Alendronate.
Department of Rheumatic Disease, Shinko Hospital0 个研究点目标入组 80 人开始时间: 2012年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with contraindication for Eldecalcitol treatments 2. Patients who are inappropriate for this study by physicians.
研究者
相似试验
已完成
不适用
The effect of Eldecalcitol for glucocorticoid induced osteoporosis patients who are not recommended bisphosphonates therapyJPRN-UMIN000009589Department of Rheumatic Disease, Shinko Hospital40
已完成
不适用
Eldecalcitol for GLucocorticoid induced OsteopoRosIs versus AlfacalcidolGlucocorticoid-induced osteoporosisJPRN-UMIN000011700e-GLORIA trial Protocol Review Committee (Executive Committee)373
Unknown
不适用
Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus AlfacalcidolOsteoporosisNCT01974167e-GLORIA trial Protocol Review Committee400
已完成
不适用
Quantitative assessment of the eldecalcitol effect on intestinal calcium absorptioPrimary osteoporosisJPRN-UMIN000020267Research secretariat (IDD, Inc.)40
已完成
不适用
Study on the glucocorticoid-sparing effects of tocilizumab among glucocorticoid-dependent patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trialAdult Still's disease or systemic juvenile idiopathic arthritisJPRN-UMIN000001250Division of Rheumatology & Clinical Immunology, Jichi Medical University10